Molecular epidemiology of malaria in Yaounde, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of plasmodium falciparum

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 4, 1998, Pages 577-581

  Basco, Leonardo K ^a   Ringwald, Pascal ^a  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PROTOZOAL DNA;

ALLELE; ARTICLE; CAMEROON; CONTROLLED STUDY; ERYTHROCYTE; GENOTYPE; HUMAN; HUMAN CELL; MALARIA; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031724298     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.577     Document Type: Article

References (48)

1. Fadat G, Louis FJ, Louis JP, Le Bras J, 1993. Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon. Antimicrob Agents Chemother 37: 1955-1957.
2. Louis JP, Hengy C, Louis FJ, Gazin P, Jambou R, Gardon J, Fadat G, Trebucq A, 1992. Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon. Trop Med Parasitol 43: 118-120.
3. Ringwald P, Bickii J, Basco LK, 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Am J Trop Med Hyg 55: 254-258.
4. Ringwald P, Bickii J, Basco LK, 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347: 24-28.
5. Le Bras J, Simon F, Ramanamirija JA, Calmel MB, Hatin I, Deloron P, Porte J, Marchais R, Clausse JL, Biaud JM, Sarrouy J, Guiguemde TR, Carme B, Charmot G, Coulaud JP, Coulanges P, 1987. Sensibilité de Plasmodium falciparum aux quinoléines et stratégies thérapeutiques: comparaison de la situation en Afrique et à Madagascar entre 1983 et 1986. Bull Soc Pathol Exot 80: 477-489.
6. Hengy C, Garrigue G, Abissegue B, Ghogomu N, Gazin P, Gelaz H, Kouka-Bemba D, Le Bras J, Jambou R, 1989. Surveillance de la chimiosensibilité de Plasmodium falciparum à Yaoundé et ses environs (Cameroun). Etude in vivo, in vitro. Bull Soc Pathol Exot 82: 217-223.
7. Brasseur P, Kouamouo J, Brandicourt O, Moyou-Somo R, Druilhe P, 1988. Patterns of in vitro resistance to chloroquine, quinine, and mefloquine of Plasmodium falciparum in Cameroon, 1985-1986. Am J Trop Med Hyg 39: 166-172.
8. Brasseur P, Kouamouo J, Moyou-Somo R, Druilhe P, 1992. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. I. Stable figures of prevalence of chloroquine-and quinine-resistant isolates in the original foci. Am J Trop Med Hyg 46: 1-7.
9. Foote SJ, Kyle DE, Martin RK, Oduola AMJ, Forsyth K, Kemp DJ, Cowman AF, 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
10. Basco LK, Le Bras J, Rhoades Z, Wilson CM, 1995. Analysis of pfmdr 1 and drug susceptibility in fresh isolates of Plasmodium falciparum from Subsaharan Africa. Mol Biochem Parasitol 74: 157-166.
11. Cox-Singh J, Singh B, Alias A, Abdullah MS, 1995. Assessment of the association between three pfmdr 1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg 89: 436-437.
12. Adagu IS, Dias F, Pinheiro L, Rombo L, do Rosario V, Warhurst DC, 1996. Guinea Bissau: association of chloroquine resistance of Plasmodium falciparum with the Tyr86 allele of the multiple drug-resistance gene Pfmdr 1. Trans R Soc Trop Med Hyg 90: 90-91.
13. Frean JA, Awad El Kariem FM, Warhurst DC, Miles MA, 1992. Rapid detection of pfmdr 1 mutations in chloroquine-resistant Plasmodium falciparum malaria by polymerase chain reaction analysis of blood spots. Trans R Soc Trop Med Hyg 86: 29-30.
14. Foote SJ, Thompson JK, Cowman AF, Kemp DL, 1989. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57: 921-930.
15. Mount DL, Nahlen BL, Patchen LC, Churchill FC, 1989. Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull World Health Organ 67: 295-300.
16. Basco LK, Le Bras J, 1992. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 47: 521-527.
17. Eldin de Pécoulas P, Basco LK, Abdallah B, Djé MK, Le Bras J, Mazabraud A, 1995. Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Exp Parasitol 80: 483-487.
18. Eldin de Pécoulas P, Basco LK, Le Bras J, Mazabraud A, 1996. Association between antifol resistance in vitro and DHFR point mutation in Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg 90: 181-182.
19. Basco LK, Eldin de Pécoulas P, Wilson CM, Le Bras J, Mazabraud A, 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69: 135-138.
20. Basco LK, Ringwald P, 1998. Molecular epidemiology of malaria in Yaoundé, Cameroon. I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg 58: 369-373.
21. Basco LK, Ringwald P, 1998. Molecular epidemiology of malana in Yaoundé, Cameroon. II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg 58: 374-378.
22. Brooks DR, Wang P, Read M, Watkins WM, Sims PFG, Hyde JE, 1994. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224: 397-405.
23. Triglia T, Cowman AF, 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7149-7153.
24. Wang P, Brooks DR, Sims PFG, Hyde JE, 1995. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol Biochem Parasitol 71: 115-125.
25. Wilson CM, Volkman SK, Thaithong S, Martin RK, Kyle DE, Milhous WK, Wirth DF, 1993. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 57: 151-160.
26. Basco LK, Eldin de Pécoulas P, Le Bras J, Wilson CM, 1996. Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Exp Parasitol 82: 97-103.
27. Awad El Kariem FM, Miles MA, Warhurst DC, 1992. Chloroquine resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr 1 gene thought to be associated with chloroquine resistance. Trans R Soc Trop Med Hyg 86: 587-589.
28. Haruki K, Bray PG, Ward SA, Hommel M, Ritchie GY, 1994. Chloroquine resistance of Plasmodium falciparum: further evidence for a lack of association with mutations of the pfmdr 1 gene. Trans R Soc Trop Med Hyg 88: 694.
29. Bhattacharya PR, Biswas S, Kabilan L, 1997. Alleles of the Plasmodium falciparum Pfmdr 1 gene appear not to be associated with chloroquine resistance in India. Trans R Soc Trop Med Hyg 91: 454-455.
30. von Seidlein L, Duraisingh MT, Drakeley CJ, Bailey R, Greenwood BM, Pinder M, 1997. Polymorphism of the Pfmdr 1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. Trans R Soc Trop Med Hyg 91: 450-453.
31. Wilson CM, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH, Wirth DF, 1989. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244: 1184-1186.
32. Cowman AF, Karcz S, Galatis D, Culvenor JG, 1991. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol 113: 1033-1042.
33. Triglia T, Foote SJ, Kemp DJ, Cowman AF, 1991. Amplification of the multidrug resistance gene pfmdr 1 in Plasmodium falciparum has arisen as multiple independent events. Mol Cell Biol 11: 5244-5250.
34. Barnes DA, Foote SJ, Galatis D, Kemp DL, Cowman AF, 1992. Selection for high-level chloroquine resistance results in deamplification of the pfmdr 1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J 11: 3067-3075.
35. Cowman AF, Galatis D, Thompson JK, 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr 1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA 91: 1143-1147.
36. Peel SA, Bright P, Yount B, Handy J, Baric RS, 1994. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum. Am J Trop Med Hyg 51: 648-658.
37. Cremer G, Basco LK, Le Bras J, Camus D, Slomianny C, 1995. Plasmodium falciparum: detection of P-glycoprotein in chloroquine-susceptible and chloroquine-resistant clones and isolates. Exp Parasitol 81: 1-8.
38. Ritchie GY, Mungthin M, Green JE, Bray PG, Hawley SR, Ward SA, 1996. In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh1. Mol Biochem Parasitol 83: 35-46.
39. Lim ASY, Galatis D, Cowman AF, 1996. Plasmodium falciparum: amplification and overexpression of pfmdr 1 is not necessary for increased mefloquine resistance. Exp Parasitol 83: 295-303.
40. Van Es HHG, Karcz S, Chu F, Cowman AF, Vidal S, Gros P, Schurr E, 1994. Expression of the plasmodial pfmdr 1 gene in mammalian cells is associated with increased susceptibility to chloroquine. Mol Cell Biol 14: 2419-2428.
41. Van Es HHG, Renkema H, Aerts H, Schurr E, 1994. Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr 1 gene. Mol Biochem Parasitol 68: 209-219.
42. Volkman SK, Cowman AF, Wirth DF, 1995. Functional complementation of the ste 6 gene of Saccharomyces cerevisiae with the pfmdr 1 gene of Plasmodium falciparum. Proc Natl Acad Sci USA 92: 8921-8925.
43. Ruetz S, Delling U, Brault M, Schurr E, Gros P, 1996. The pfmdr 1 gene of Plasmodium falciparum confers cellular resistance to antimalarial drugs in yeast cells. Proc Natl Acad Sci USA 93: 9942-9947.
44. Wellems TE, Walker-Jonah A, Panton LJ, 1991. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc Natl Acad Sci USA 88: 3382-3386.
45. Wellems TE, Panton LJ, Gluzman IY, do Rosario VE, Gwadz RW, Walker-Jonah A, Krogstad DJ, 1990. Chloroquine resistance not linked to mdr-like genes in Plasmodium falciparum cross. Nature 345: 253-255.
46. Su XZ, Kirkman LA, Fujioka H, Wellems TE, 1997. Complex polymorphisms in an ∼330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91: 593-603.
47. Basco LK, Ringwald P, 1997. Pfmdr 1 gene mutation and clinical response to chloroquine in Yaoundé, Cameroon. Trans R Soc Trop Med Hyg 91: 210-211.
48. Duraisingh MT, Drakeley CJ, Muller O, Bailey R, Snounou G, Targett GAT, Greenwood BM, Warhurst DC, 1997. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114: 205-211.